Dr. Fenstermaker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-8980- Is this information wrong?
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurological Surgery, 1988 - 1989
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurological Surgery, 1982 - 1987
- Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Transitional Year, 1981 - 1982
- Northeast Ohio Medical UniversityClass of 1981
Certifications & Licensure
- NY State Medical License 1994 - 2026
- OH State Medical License 1986 - 2007
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2022
- Buffalo Spree Magazine Castle Connolly, 2006, 2008, 2010-2016
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
- Join now to see all
Clinical Trials
- Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma Start of enrollment: 2012 Sep 05
- SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2015 May 04
- Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac® Start of enrollment: 2023 Apr 11
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Survivin in lung cancer: a potential target for therapy and prevention-a narrative review.Akhil Goud Pachimatla, Michael Ciesielski, Robert Fenstermaker, Sai Yendamuri> ;Translational Lung Cancer Research. 2024 Feb 29
- 1 citationsFunctional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma.Galbo, P., Madsen, A., Liu, Y., Peng, M., Wei, Y., Ciesielski, M., Graff, S., Montagna, C., Segall, J., Sidoli, S., Zang, X., Zheng, D., Fenstermaker, R.> ;Clinical Cancer Research. 2024 Feb 16
- 1 citationsBevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma.Zhang, J., Okai, B., Attwood, K., Iovoli, A., Goulenko, V., Lim, J., Hess, R., Abad, A., Prasad, D., Fenstermaker, R.> ;Journal of Neuro-Oncology. 2024 Jan 1
- Join now to see all
Journal Articles
- Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed GlioblastomaManmeet S Ahluwalia, David A Reardon, Ajay P Abad, William T Curry, Eric T Wong, Sheila A Figel, Laszlo L Mechtler, David M Peereboom, Alan D Hutson, Henry G Withers, ..., J Clin Oncol, 12/15/2022
Press Mentions
- Castle Connolly Names 38 Roswell Park Physicians to ‘Top Doctors’ ListFebruary 2nd, 2023
- Roswell Park Oncology Experts Named to Castle Connolly ‘Top Doctors’ ListAugust 4th, 2022
- Roswell Park-Developed Immunotherapy Now Part of Nationwide Study in Kids with Brain CancerJune 7th, 2022
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
Hospital Affiliations
- Roswell Park Comprehensive Cancer CenterBuffalo, New York
Industry Relationships
- co-Founder and Chief Medical Officer, MimiVax, LLCMimiVax, LLC is a biotechnology company focused on immuno-oncology2012 - 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: